Organic compositions to treat HSF1-related diseases
The present disclosure relates to methods of treating heat stock factor 1 (HSF1)-related diseases such as cancer, autoimmune and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.
Arrowhead Pharmaceuticals, Inc.
C A C C A A C A A C C A A A C C C C A
C12N A61P C12N C12N A61P A61K C12N A61P A61P C12N C12N A61K A61P A61P C12N C12N C12N C12N A61K
additional inventional additional additional inventional inventional additional inventional inventional additional additional inventional inventional inventional additional additional inventional additional inventional
Mark Frank Dieter Wenlai Jinyun Chandra Jan Kalyani
Stump Stegmeier Huesken Zhou Chen Vargeese Weiler Gampa